Data from clinical studies has shown that renalase level significantly decrease in patients with stroke and chronic kidney diseases, especially those on renal replacement therapy [39]–[41], and is normalized in kidney and heart transplant recipients [42], [43]. Here, RNLS is linked to chronic kidney disease.